66
CORDLIFE GROUP LIMITED
| ANNUAL REPORT 2015
NOTES TO THE FINANCIAL STATEMENTS
FOR THE FINANCIAL YEAR ENDED 30 JUNE 2015
1.
CORPORATE INFORMATION
The Company is a limited liability company incorporated and domiciled in Singapore and is listed on the
Singapore Exchange Securities Trading Limited (“SGX-ST”).
The Company’s registered office and principal place of business is located at 1 Yishun Industrial Street 1,
#06-01/09, A’Posh Bizhub, Singapore 768160.
The principal activities of the Company are investment holding and the provision of cord blood banking
services, which involves the processing and storage of stem cells. The principal activities of the subsidiaries
are disclosed in Note 32 to the financial statements.
2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
2.1 Basis of preparation
The consolidated financial statements of the Group and the statement of financial position and
statement of changes of equity of the Company have been prepared in accordance with Singapore
Financial Reporting Standards (“FRS”). The financial statements have been prepared on a historical cost
basis except as disclosed in the accounting policies below.
The financial statements are presented in Singapore Dollars (SGD or $), and all values are rounded to
the nearest thousand ($’000) except otherwise indicated.
2.2 Changes in accounting policies
The accounting policies adopted are consistent with those of the previous financial year except in the
current financial year, the Group has adopted all the new and revised standards which are effective
for annual financial periods beginning on or after 1 July 2014. The adoption of these standards did not
have any effect on the financial performance or position of the Group and the Company.
